Inhibitor Therapeutics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Inhibitor Therapeutics, Inc. (INTI) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$153.75 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2017-02-17
- Inhibitor Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was -$153.75K, a 201.83% decline from fiscal 2015.
- Inhibitor Therapeutics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $150.98K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|
| 2016-12-31 | -$153.75K 10-K · filed 2017-02-17 |
| 2015-12-31 | $150.98K 10-K · filed 2017-02-17 |